Chronic L-deprenyl or L-amphetamine: Equal cognitive enhancement, unequal MAO inhibition

This publication has 33 references indexed in Scilit:

• Improvement of cognitive function by MAO-B inhibitor L-deprenyl in aged rats
  Pharmacology Biochemistry and Behavior, 1991
• Oxygen Free Radicals and Brain Dysfunction
  International Journal of Neuroscience, 1991
• The pharmacology of selegiline ((−)deprenyl). New aspects
  Acta Neurologica Scandinavica, 1989
• Striatal dopamine, sexual activity and lifespan. Longevity of rats treated with (-) deprenyl
  Life Sciences, 1989
• Deprenyl as Symptomatic Therapy in Parkinsonʼs Disease
  Clinical Neuropharmacology, 1988
• The striatal dopamine dependency of life span in male rats. Longevity study with (−)deprenyl
  Mechanisms of Ageing and Development, 1988
• (-)-Deprenyl Leads to Prolongation of L-Dopa Efficacy in Parkinson s Disease
  Published by S. Karger AG ,1982
• Metabolism of (‐) deprenyl to amphetamine and methamphetamine may be responsible for deprenyl's therapeutic benefit
  Neurology, 1982
• The effect of age on the activity and molecular properties of human brain monoamine oxidase
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1980
• The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenil
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1975